Geisinger Proposes Amendments to RBC Requirements Affecting Acquisition Strategy
Kaiser Foundation Hospitals and Risant Health face significant challenges in altering their acquisition strategy involving Geisinger Indemnity Insurance Co. and related entities. The proposed amendments focus on reducing risk-based capital (RBC) requirements, submitted to the Pennsylvania Insurance Department on January 16, 2026. This adjustment is driven by a fixed-rate initiative from the Centers for Medicare and Medicaid Services, increased specialty drug expenses, and legislative changes affecting federal health programs.
Geisinger Health had invested $2.6 billion in expansion prior to these developments. Initially, the 2024 approval mandated that Geisinger Indemnity Insurance Co. and Geisinger Quality Options Inc. maintain an RBC level of at least 400%, with Geisinger Health Plans required to sustain it at or above 350% for the first five years. Following this period, the entire enterprise was expected to maintain a 350% level.
Geisinger now proposes to lower the minimum RBC requirement to 300% for all three entities, extending over 15 years from the acquisition's effective date. This change could potentially release $100 million in capital. The proposed level remains 1.5 times higher than the recommendations by the National Association of Insurance Commissioners, aligning with historical requirements for these entities.
In December 2025, U.S. insurance regulators updated RBC framework principles, emphasizing their importance as early-warning systems for undercapitalized entities. These revisions aim to support modernization and ensure equivalent capital allocation for similar risks within the insurance industry.
Action Together NEPA opposes the proposed RBC changes, citing Geisinger's approved premium increases amid escalating healthcare costs in 2025. The group suggests rejecting the change or imposing cost control conditions on any approved modifications. SEIU Healthcare Pennsylvania also opposes the plan, observing a 33% increase in healthcare costs from 2023 to 2025. They advocate for exploring resource reallocation and urge using part of Kaiser's $82 billion net worth to improve access and affordability, linking any approval to commitments for cost reduction or stabilization.
In response to public comments, on March 12, Risant Health and Geisinger clarified their request focuses on RBC requirements and does not alter the original capital commitments from the 2024 approval. Geisinger maintains that the proposed RBC adjustments would bolster their capacity for funding care quality improvements. As of now, the Pennsylvania Insurance Department has not rendered a decision on this request.